Patel et al. (27) showed that this chimeric EWS-FLI TF targets different genomic regions in tumor cells and in non-tumor cells, and that additionally the wild-type protein FLI1 binds to largely the same regions as the fusion protein in non-tumor cells. This evidence concerns the gene TF and neoplasm.